Acurx Pharmaceuticals, Inc.

CUSIP 007025802COM NEWQ4 2025

Acurx Pharmaceuticals, Inc. — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

8.7%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest Nov 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Nov 14, 2025	Armistice Capital, LLC	13G/A	5.0%	83.2K	SEC
2	Aug 14, 2025	Armistice Capital, LLC	13G	8.7%	2.92M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Ifp Advisors, Inc	1	$0